Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionaldehyde SCHEMBL1523503 | 0.84 | LMNA (0.67) | LMNATHRBALDH1A1MAPK1TDP1 | |
| Formamide SCHEMBL856006 | 0.84 | LMNA (0.67) | LMNATHRB | |
| SCHEMBL2917881 | 0.84 | LMNA (0.52) | LMNATHRBALDH1A1MEN1CYP1A2 | |
| SCHEMBL11485155 | 0.82 | LMNA (0.63) | LMNATHRBALDH1A1MAPK1TDP1 | |
| Malonaldehyde SCHEMBL6704192 | 0.82 | LMNA (0.63) | LMNATHRBALDH1A1MAPK1TDP1 | |
| SCHEMBL4293299 | 0.81 | LMNA (0.71) | LMNATHRBALDH1A1MAPK1TDP1 | |
| Acetaldehyde SCHEMBL212729 | 0.81 | LMNA (0.71) | LMNATHRBALDH1A1MAPK1TDP1 | |
| 4-Aminobutanal SCHEMBL1437073 | 0.81 | LMNA (0.48) | LMNAALDH1A1MEN1CYP1A2KMT2A | |
| Butane SCHEMBL8312214 | 0.80 | LMNA (0.60) | LMNATHRB | |
| SCHEMBL8039396 | 0.80 | LMNA (0.60) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 414 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118530196-A | Method for synthesizing 1- (2-aminoethyl) pyrrolidine by continuous hydrogenation reduction | 扬州市普林斯医药科技有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-115541784-A | Method for detecting related substances in methimazole | 宁夏回族自治区药品检验研究院 | 2022-12-30 | — | — | CN | claimed |
| CN-109575035-B | Preparation method of medicine Rucaparib intermediate for treating ovarian cancer | 江苏开元药业有限公司 | 2021-04-16 | — | — | CN | claimed |
| US-10975096-B2 | Synthesis of polycyclic-carbamoylpyridone compounds | GILEAD SCIENCES, INC. (US) | 2021-04-13 | — | — | US | claimed |
| EP-3783001-A1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | Gilead Sciences, Inc. (US) | 2021-02-24 | — | — | EP | claimed |
| US-20200223866-A1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | GILEAD SCIENCES, INC. | 2020-07-16 | — | — | US | claimed |
| CN-109575035-A | A kind of preparation method for treating ovarian cancer Rucaparib intermediate | 江苏开元药业有限公司 | 2019-04-05 | — | — | CN | claimed |
| EP-2923692-B1 | Beta-amino ester compounds and uses thereof | LIVING PROOF INC (US) | 2018-05-30 | — | — | EP | claimed |
| EP-2245132-B1 | ENCAPSULATED BENEFIT AGENT | UNILEVER PLC NO 41424 (GB) | 2017-10-18 | — | — | EP | claimed |
| EP-3157933-A2 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | Gilead Sciences, Inc. (US) | 2017-04-26 | — | — | EP | claimed |
| WO-2015195656-A2 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | GILEAD SCIENCES ,INC. (US) | 2015-12-23 | — | — | WO | claimed |
| CN-103396369-A | Method for preparing 2-chloro-4-nitroimidazole | YANCHENG INST TECHNOLOGY | 2013-11-20 | — | — | CN | claimed |
| EP-1029865-B1 | Process for preparing 5-lipoxygenase inhibitors | PFIZER PROD INC (US) | 2004-04-28 | — | — | EP | claimed |
| WO-2002020493-A2 | A TRACELESS SOLID-PHASE SYNTHESIS OF 2-IMIDAZOLONES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-03-14 | — | — | WO | claimed |
| EP-0389189-B1 | Diazepine antiallergy agents | PFIZER LTD (GB) | 1994-05-18 | — | — | EP | claimed |
| EP-0212066-B1 | INTERMEDIATES USEFUL IN THE PREPARATION OF DOPAMINE-BETA-HYDROXYLASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1990-11-22 | — | — | EP | claimed |
| EP-0221778-A2 | Dopamine-beta-hydroxylase inhibitors | SMITHKLINE BECKMAN CORPORATION (US) | 1987-05-13 | — | — | EP | claimed |
| EP-0212066-A1 | Intermediates useful in the preparation of dopamine-beta-hydroxylase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1987-03-04 | — | — | EP | claimed |
| US-4137268-A | Method of preparing aminoacetaldehyde acetals by the hydrogenation of dialkoxyacetonitrile | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1979-01-30 | — | — | US | claimed |
| CN-118530196-B | Method for synthesizing 1- (2-aminoethyl) pyrrolidine by continuous hydrogenation reduction | 扬州市普林斯医药科技有限公司 | 2026-03-24 | — | — | CN | disclosed |
| CN-119569586-A | Synthesis method of aminoacetaldehyde dimethyl acetal | 新沂市永诚化工有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119569586-A | Synthesis method of aminoacetaldehyde dimethyl acetal | 新沂市永诚化工有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-12202836-B2 | Bicyclic-fused heteroaryl or aryl compounds | PFIZER INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-12091407-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | VTV THERAPEUTICS LLC (US) | 2024-09-17 | — | — | US | disclosed |
| CN-118530196-A | Method for synthesizing 1- (2-aminoethyl) pyrrolidine by continuous hydrogenation reduction | 扬州市普林斯医药科技有限公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-118530196-A | Method for synthesizing 1- (2-aminoethyl) pyrrolidine by continuous hydrogenation reduction | 扬州市普林斯医药科技有限公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-118290334-A | Preparation method of Lifeiste key intermediate | 上海医药工业研究院有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20230381170-A1 | METHOD FOR TREATING ALS/FTD THROUGH DEGRADATION OF RNA REPEAT EXPANSION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-11-30 | — | — | US | disclosed |
| CN-111253336-B | Compounds for the treatment of cancer | GTX公司 | 2023-11-21 | — | — | CN | disclosed |
| US-20230339960-A1 | Bicyclic-Fused Heteroaryl or Aryl Compounds | PFIZER (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230312548-A1 | SUBSTITUTE FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | VTV THERAPEUTICS LLC | 2023-10-05 | — | — | US | disclosed |
| CN-111542516-B | IRAK4 inhibitors and uses thereof | 新标立亚医疗有限公司 | 2023-07-18 | — | — | CN | disclosed |
| US-11702424-B2 | Bicyclic-fused heteroaryl or aryl compounds | PFIZER INC. (US) | 2023-07-18 | — | — | US | disclosed |
| US-11649230-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | VTV THERAPEUTICS LLC (US) | 2023-05-16 | — | — | US | disclosed |
| CN-115650973-A | NSC69187 and synthesis method and application of derivative thereof | 南方医科大学 | 2023-01-31 | — | — | CN | disclosed |
| CN-115541784-A | Method for detecting related substances in methimazole | 宁夏回族自治区药品检验研究院 | 2022-12-30 | — | — | CN | disclosed |
| CN-110317212-B | Synthesis of polycyclic carbamoylpyridone compounds | 吉利德科学公司 | 2022-10-21 | — | — | CN | disclosed |
| EP-3527573-B9 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | GILEAD SCIENCES INC (US) | 2022-07-06 | — | — | EP | disclosed |
| US-20220169641-A1 | Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof | VTVX HOLDINGS II LLC | 2022-06-02 | — | — | US | disclosed |
| WO-2022086851-A1 | METHOD FOR TREATING ALS/FTD THROUGH DEGRADATION OF RNA REPEAT EXPANSION | THE SCRIPPS RESEARCH INSTITUTE (US) | 2022-04-28 | — | — | WO | disclosed |
| CN-114394983-A | Synthesis of polycyclic carbamoylpyridone compounds | 吉利德科学公司 | 2022-04-26 | — | — | CN | disclosed |
| EP-3536685-B1 | BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS | PFIZER (US) | 2022-02-16 | — | — | EP | disclosed |
| CN-109219609-B | Fused hexacyclic imidazole derivatives as modulators of TNF activity | UCB生物制药私人有限公司 | 2022-02-01 | — | — | CN | disclosed |
| US-11130753-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | VTV THERAPEUTICS LLC (US) | 2021-09-28 | — | — | US | disclosed |
| EP-3339303-B9 | ARYL AND HETEROARYL FUSED LACTAMS | PFIZER (US) | 2021-07-21 | — | — | EP | disclosed |
| CN-110039069-B | Spongy micron copper powder and preparation method thereof | 江西省科学院能源研究所 | 2021-05-14 | — | — | CN | disclosed |
| CN-109575035-B | Preparation method of medicine Rucaparib intermediate for treating ovarian cancer | 江苏开元药业有限公司 | 2021-04-16 | — | — | CN | disclosed |
| CN-109575035-B | Preparation method of medicine Rucaparib intermediate for treating ovarian cancer | 江苏开元药业有限公司 | 2021-04-16 | — | — | CN | disclosed |
| US-10975096-B2 | Synthesis of polycyclic-carbamoylpyridone compounds | GILEAD SCIENCES, INC. (US) | 2021-04-13 | — | — | US | disclosed |
| CN-112513049-A | Heterocyclic compounds and their use in the prevention or treatment of bacterial infections | 拜欧蒂姆公司 | 2021-03-16 | — | — | CN | disclosed |
| CN-106794174-B | Compounds for the treatment of cancer | GTX公司 | 2021-03-12 | — | — | CN | disclosed |
| CN-110372631-B | Preparation method of aminothiazoly loximate acetaldehyde | 东南大学成贤学院 | 2021-03-02 | — | — | CN | disclosed |
| EP-3783001-A1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | Gilead Sciences, Inc. (US) | 2021-02-24 | — | — | EP | disclosed |
| US-10889580-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | VTV THERAPEUTICS LLC (US) | 2021-01-12 | — | — | US | disclosed |
| US-20210002268-A1 | Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof | TRANSTECH PHARMA, INC. | 2021-01-07 | — | — | US | disclosed |
| US-20200385370-A1 | APPARATUS FOR REMOVING BAD ODOR FROM TOILET | SYNBLIA THERAPEUTICS, INC. | 2020-12-10 | — | — | US | disclosed |
| US-20200377511-A1 | Bicyclic-Fused Heteroaryl or Aryl Compounds | PFIZER INC. (US) | 2020-12-03 | — | — | US | disclosed |
| CN-106458912-B | Bicyclic fused heteroaryl or aryl compounds and their use as IRAK4 mimetics | 辉瑞公司 | 2020-10-27 | — | — | CN | disclosed |
| US-10793579-B2 | Bicyclic-fused heteroaryl or aryl compounds | PFIZER INC. (US) | 2020-10-06 | — | — | US | disclosed |
| EP-3704104-A1 | IRAK4 INHIBITORS AND USES THEREOF | Synblia Therapeutics, Inc. (US) | 2020-09-09 | — | — | EP | disclosed |
| CN-111542516-A | IRAK4 inhibitors and uses thereof | 新标立亚医疗有限公司 | 2020-08-14 | — | — | CN | disclosed |
| EP-3527573-B1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | GILEAD SCIENCES INC (US) | 2020-08-12 | — | — | EP | disclosed |
| US-20200223866-A1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | GILEAD SCIENCES, INC. | 2020-07-16 | — | — | US | disclosed |
| EP-3339303-B1 | ARYL AND HETEROARYL FUSED LACTAMS | PFIZER (US) | 2020-06-24 | — | — | EP | disclosed |
| CN-111253336-A | Compounds for the treatment of cancer | GTX公司 | 2020-06-09 | — | — | CN | disclosed |
| US-20200148673-A1 | Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof | VTVX HOLDINGS II LLC | 2020-05-14 | — | — | US | disclosed |
| CN-108290863-B | Substituted aminotriazoles useful as human chitinase inhibitors | 昂科艾伦迪治疗法公司 | 2020-05-05 | — | — | CN | disclosed |
| US-10570126-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | VTV THERAPEUTICS LLC (US) | 2020-02-25 | — | — | US | disclosed |
| CN-110709392-A | Isoquinoline as HPK1 inhibitors | 豪夫迈·罗氏有限公司 | 2020-01-17 | — | — | CN | disclosed |
| US-20190345137-A1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS HUMAN CHITINASE INHIBITORS | GALAPAGOS NV (BE) | 2019-11-14 | — | — | US | disclosed |
| CN-110317212-A | The synthesis of polycyclic carbamoylpyridone compound | 吉利德科学公司 | 2019-10-11 | — | — | CN | disclosed |
| EP-3536685-A1 | BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS | Pfizer Inc (US) | 2019-09-11 | — | — | EP | disclosed |
| US-20190270751-A1 | Bicyclic-Fused Heteroaryl or Aryl Compounds | PFIZER INC. (US) | 2019-09-05 | — | — | US | disclosed |
| EP-3527573-A1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | Gilead Sciences, Inc. (US) | 2019-08-21 | — | — | EP | disclosed |
| US-20190194181-A1 | Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof | TRANSTECH PHARMA, INC. | 2019-06-27 | — | — | US | disclosed |
| US-10329302-B2 | Bicyclic-fused heteroaryl or aryl compounds | PFIZER INC. (US) | 2019-06-25 | — | — | US | disclosed |
| US-10287284-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | VTV THERAPEUTICS LLC (US) | 2019-05-14 | — | — | US | disclosed |
| CN-106470975-B | Synthesis of polycyclic carbamoylpyridone compounds | 吉利德科学公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-109575035-A | A kind of preparation method for treating ovarian cancer Rucaparib intermediate | 江苏开元药业有限公司 | 2019-04-05 | — | — | CN | disclosed |
| CN-109575035-A | A kind of preparation method for treating ovarian cancer Rucaparib intermediate | 江苏开元药业有限公司 | 2019-04-05 | — | — | CN | disclosed |
| US-10246433-B2 | Aryl and heteroaryl fused lactams | PFIZER INC. (US) | 2019-04-02 | — | — | US | disclosed |
| US-10208020-B2 | Substituted amino triazoles useful as human chitinase inhibitors | Oncoarendi Therapeutics S.A. (PL) | 2019-02-19 | — | — | US | disclosed |
| EP-3344616-B1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS HUMAN CHITINASE INHIBITORS | ONCOARENDI THERAPEUTICS SA (PL) | 2019-01-09 | — | — | EP | disclosed |
| US-20180291015-A1 | Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof | TRANSTECH PHARMA, INC. | 2018-10-11 | — | — | US | disclosed |
| US-20180258071-A1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS HUMAN CHITINASE INHIBITORS | GALAPAGOS NV (BE) | 2018-09-13 | — | — | US | disclosed |
| US-10030011-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | VTV THERAPEUTICS LLC (US) | 2018-07-24 | — | — | US | disclosed |
| EP-3344616-A1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS HUMAN CHITINASE INHIBITORS | ONCOARENDI THERAPEUTICS S.A. (PL) | 2018-07-11 | — | — | EP | disclosed |
| US-10011598-B2 | Small molecules targeting repeat r(CGG) sequences | THE SCRIPPS RESEARCH INSTITUTE (US) | 2018-07-03 | — | — | US | disclosed |
| EP-3339303-A1 | ARYL AND HETEROARYL FUSED LACTAMS | Pfizer Inc (US) | 2018-06-27 | — | — | EP | disclosed |
| US-20180127432-A1 | Bicyclic-Fused Heteroaryl or Aryl Compounds | PFIZER INC. (US) | 2018-05-10 | — | — | US | disclosed |
| EP-2536285-B1 | SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | VTV THERAPEUTICS LLC (US) | 2018-04-25 | — | — | EP | disclosed |
| US-9944624-B2 | Substituted amino triazoles useful as human chitinase inhibitors | Oncoarendi Therapeutics S.A. (PL) | 2018-04-17 | — | — | US | disclosed |
| US-9902710-B2 | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) | EXONHIT THERAPEUTICS, SA (FR) | 2018-02-27 | — | — | US | disclosed |
| US-9879022-B2 | Bicyclic-fused heteroaryl or aryl compounds | PFIZER INC. (US) | 2018-01-30 | — | — | US | disclosed |
| US-20180022757-A1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | GILEAD SCIENCES, INC. | 2018-01-25 | — | — | US | disclosed |
| EP-2935238-B1 | ARYL AND HETEROARYL FUSED LACTAMS | PFIZER (US) | 2017-12-27 | — | — | EP | disclosed |
| US-9809489-B2 | Composition for forming a conductive film, a conductive film, a method for producing a plating film, a plating film, and an electronic device | JSR CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| WO-2017184765-A1 | KAPPA OPIOID RECEPTOR COMPOUNDS AND METHODS OF USING SAME | MediSynergics, LLC (US) | 2017-10-26 | — | — | WO | disclosed |
| US-20170233368-A1 | ARYL AND HETEROARYL FUSED LACTAMS | PFIZER INC. (US) | 2017-08-17 | — | — | US | disclosed |
| US-9700563-B2 | Kappa opioid receptor compounds | MediSynergies, LLC (US) | 2017-07-11 | — | — | US | disclosed |
| US-9675606-B2 | 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors | SANOFI (FR) | 2017-06-13 | — | — | US | disclosed |
| US-20170152261-A1 | SMALL MOLECULES TARGETING REPEAT r(CGG) SEQUENCES | THE SCRIPPS RESEARCH INSTITUTE | 2017-06-01 | — | — | US | disclosed |
| EP-3157933-A2 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | Gilead Sciences, Inc. (US) | 2017-04-26 | — | — | EP | disclosed |
| US-20170066743-A1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS HUMAN CHITINASE INHIBITORS | GALAPAGOS NV (BE) | 2017-03-09 | — | — | US | disclosed |
| WO-2017037670-A1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS HUMAN CHITINASE INHIBITORS | OncoArendi Therapeutics Sp. z o.o. (PL) | 2017-03-09 | — | — | WO | disclosed |
| EP-2748167-B1 | HEPATITIS C INHIBITOR COMPOUNDS | BOEHRINGER INGELHEIM INT (DE) | 2017-03-01 | — | — | EP | disclosed |
| CN-106470975-A | Synthesis of Polycyclic Carbamoylpyridone Compounds | 吉利德科学公司 | 2017-03-01 | — | — | CN | disclosed |
| EP-3126330-A1 | BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS | Pfizer Inc (US) | 2017-02-08 | — | — | EP | disclosed |
| US-9550769-B2 | Small molecules targeting repeat r(CGG) sequences | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-01-24 | — | — | US | disclosed |
| US-9543201-B2 | Method for forming three-dimensional interconnection, circuit arrangement comprising three-dimensional interconnection, and metal film-forming composition for three-dimensional interconnection | JSR CORPORATION (JP) | 2017-01-10 | — | — | US | disclosed |
| US-9520574-B2 | Electroluminescent devices based on phosphorescent iridium and related group VIII metal multicyclic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-12-13 | — | — | US | disclosed |
| US-20160347760-A1 | Bicyclic-Fused Heteroaryl or Aryl Compounds | PFIZER INC. (US) | 2016-12-01 | — | — | US | disclosed |
| US-9475788-B2 | Antiprotozoal compounds | MediSynergics, LLC (US) | 2016-10-25 | — | — | US | disclosed |
| US-9458168-B2 | Bicyclic-fused heteroaryl or aryl compounds | PFIZER INC. (US) | 2016-10-04 | — | — | US | disclosed |
| US-20160264549-A1 | SUBSTITUTED 6, 7-DIALKOXY-3-ISOQUINOLINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE 10A) | EXONHIT THERAPEUTICS, SA (FR) | 2016-09-15 | — | — | US | disclosed |
| US-20160235759-A1 | Kappa Opioid Receptor Compounds | MediSynergics, LLC (US) | 2016-08-18 | — | — | US | disclosed |
| US-9346777-B2 | Antiprotozoal compounds | MediSynergics, LLC (US) | 2016-05-24 | — | — | US | disclosed |
| US-9340548-B2 | Substituted pyrazolo[3,4-a]carbazoles as hepatitis C inhibitors | Boehringer Ingehleim International GmbH (DE) | 2016-05-17 | — | — | US | disclosed |
| CN-103396369-B | A kind of method preparing the chloro-4-nitroimidazole of 2- | YANGCHENG INSTITUTE OF TECHNOLOGY (CN) | 2016-03-23 | — | — | CN | disclosed |
| CN-103396369-B | A kind of method preparing the chloro-4-nitroimidazole of 2- | YANGCHENG INSTITUTE OF TECHNOLOGY (CN) | 2016-03-23 | — | — | CN | disclosed |
| US-20160081189-A1 | COMPOSITION FOR FORMING A CONDUCTIVE FILM, A CONDUCTIVE FILM, A METHOD FOR PRODUCING A PLATING FILM, A PLATING FILM, AND AN ELECTRONIC DEVICE | JSR CORPORATION (JP) | 2016-03-17 | — | — | US | disclosed |
| US-9284291-B2 | Kappa opioid receptor compounds | MediSynergies, LLC (US) | 2016-03-15 | — | — | US | disclosed |
| US-20160064280-A1 | METHOD FOR FORMING THREE-DIMENSIONAL INTERCONNECTION, CIRCUIT ARRANGEMENT COMPRISING THREE-DIMENSIONAL INTERCONNECTION, AND METAL FILM-FORMING COMPOSITION FOR THREE-DIMENSIONAL INTERCONNECTION | JSR CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
| US-20160057866-A1 | METAL FILM FORMING METHOD AND CONDUCTIVE INK USED IN SAID METHOD | JSR CORPORATION (JP) | 2016-02-25 | — | — | US | disclosed |
| US-20160039799-A1 | Antiprotozoal Compounds | MediSynergics, LLC (US) | 2016-02-11 | — | — | US | disclosed |
| US-20160031844-A1 | Kappa Opioid Receptor Compounds | GODEK DENNIS MICHAEL (US) | 2016-02-04 | — | — | US | disclosed |
| US-20150368264-A1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | GILEAD SCIENCES, INC. | 2015-12-24 | — | — | US | disclosed |
| WO-2015195656-A2 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | GILEAD SCIENCES ,INC. (US) | 2015-12-23 | — | — | WO | disclosed |
| US-9200016-B2 | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) | ALLERGAN, INC. (US) | 2015-12-01 | — | — | US | disclosed |
| US-20150328205-A1 | 2-AMINO-3-(IMIDAZOL-2-YL)-PYRIDIN-4-ONE DERIVATIVES AND THEIR USE AS VEGF RECEPTOR KINASE INHIBITORS | SANOFI (FR) | 2015-11-19 | — | — | US | disclosed |
| US-20150307487-A1 | SMALL MOLECULES TARGETING REPEAT r(CGG) SEQUENCES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2015-10-29 | — | — | US | disclosed |
| EP-2935238-A1 | ARYL AND HETEROARYL FUSED LACTAMS | Pfizer Inc. (US) | 2015-10-28 | — | — | EP | disclosed |
| US-20150291592-A1 | HEPATITIS C INHIBITOR COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2015-10-15 | — | — | US | disclosed |
| WO-2015150995-A1 | BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS | PFIZER INC. (US) | 2015-10-08 | — | — | WO | disclosed |
| US-20150284405-A1 | Bicyclic-Fused Heteroaryl or Aryl Compounds | PFIZER INC. (US) | 2015-10-08 | — | — | US | disclosed |
| EP-2628741-B1 | NOVEL COMPOUND OF A REVERSE-TURN MIMETIC AND A PRODUCTION METHOD AND USE THEREFOR | JW PHARMACEUTICAL CORP (KR) | 2015-10-07 | — | — | EP | disclosed |
| US-9126972-B2 | 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors | SANOFI (FR) | 2015-09-08 | — | — | US | disclosed |
| CN-104870446-A | Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors | NERVIANO MEDICAL SCIENCES SRL | 2015-08-26 | — | — | CN | disclosed |
| US-20150175572-A1 | ARYL AND HETEROARYL FUSED LACTAMS | PFIZER INC. (US) | 2015-06-25 | — | — | US | disclosed |
| EP-2709996-B1 | 2-AMINO-3-(IMIDAZOL-2-YL)-PYRIDIN-4-ONE DERIVATIVES AND THEIR USE AS VEGF RECEPTOR KINASE INHIBITORS | SANOFI SA (FR) | 2015-06-24 | — | — | EP | disclosed |
| WO-2015084731-A1 | ALDEHYDE DEHYDROGENASE INHIBITORS AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2015-06-11 | — | — | WO | disclosed |
| US-20150158895-A1 | SUBSTITUTED 6, 7-DIALKOXY-3-ISOQUINOLINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE 10A) | ALLERGAN, INC. (US) | 2015-06-11 | — | — | US | disclosed |
| US-9040515-B2 | Aryl and heteroaryl fused lactams | PFIZER INC. (US) | 2015-05-26 | — | — | US | disclosed |
| US-20150038507-A1 | Antiprotozoal Compounds | GODEK DENNIS MICHAEL (US) | 2015-02-05 | — | — | US | disclosed |
| US-8940739-B2 | Compound of a reverse-turn mimetic and a production method and use therefor | JW PHARMACEUTICAL CORPORATION (KR) | 2015-01-27 | — | — | US | disclosed |
| EP-1841504-B1 | SUBSTITUTED BIARYL COMPOUNDS AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2014-11-19 | — | — | EP | disclosed |
| US-20140194349-A1 | HIV Protease Inhibiting Compounds | ABBVIE INC. (US) | 2014-07-10 | — | — | US | disclosed |
| EP-2748167-A1 | HEPATITIS C INHIBITOR COMPOUNDS | Boehringer Ingelheim International GmbH (DE) | 2014-07-02 | — | — | EP | disclosed |
| US-20140179667-A1 | ARYL AND HETEROARYL FUSED LACTAMS | PFIZER INC. (US) | 2014-06-26 | — | — | US | disclosed |
| WO-2014097041-A1 | ARYL AND HETEROARYL FUSED LACTAMS | PFIZER INC. (US) | 2014-06-26 | — | — | WO | disclosed |
| US-8759535-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | HIGH POINT PHARMACEUTICALS, LLC (US) | 2014-06-24 | — | — | US | disclosed |
| EP-2709996-A1 | 2-AMINO-3-(IMIDAZOL-2-YL)-PYRIDIN-4-ONE DERIVATIVES AND THEIR USE AS VEGF RECEPTOR KINASE INHIBITORS | SANOFI (FR) | 2014-03-26 | — | — | EP | disclosed |
| WO-2014036395-A1 | SMALL MOLECULES TARGETING REPEAT r(CGG) SEQUENCES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2014-03-06 | — | — | WO | disclosed |
| US-8653141-B2 | HIV protease inhibiting compounds | ABBVIE INC. (US) | 2014-02-18 | — | — | US | disclosed |
| CN-103396369-A | Method for preparing 2-chloro-4-nitroimidazole | YANCHENG INST TECHNOLOGY | 2013-11-20 | — | — | CN | disclosed |
| CN-103396369-A | Method for preparing 2-chloro-4-nitroimidazole | YANCHENG INST TECHNOLOGY | 2013-11-20 | — | — | CN | disclosed |
| CN-101616909-B | Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase | SANOFI AVENTIS SPA | 2013-09-11 | — | — | CN | disclosed |
| EP-2628741-A2 | NOVEL COMPOUND OF A REVERSE-TURN MIMETIC AND A PRODUCTION METHOD AND USE THEREFOR | JW Pharmaceutical Corporation (KR) | 2013-08-21 | — | — | EP | disclosed |
| EP-2264032-B1 | HIV PROTEASE INHIBITING SULFONAMIDES | ABBVIE INC (US) | 2013-08-07 | — | — | EP | disclosed |
| US-20130196972-A1 | NOVEL COMPOUND OF A REVERSE-TURN MIMETIC AND A PRODUCTION METHOD AND USE THEREFOR | JW PHARMACEUTICAL CORPORATION (KR) | 2013-08-01 | — | — | US | disclosed |
| US-20130131018-A1 | SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS | EXONHIT S.A. (FR) | 2013-05-23 | — | — | US | disclosed |
| EP-2576514-A1 | SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS | EXONHIT SA (FR) | 2013-04-10 | — | — | EP | disclosed |
| US-20130082248-A1 | ELECTROLUMINESCENT DEVICES BASED ON PHOSPHORESCENT IRIDIUM AND RELATED GROUP VIII METAL MULTICYCLIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-04-04 | — | — | US | disclosed |
| CN-102971316-A | Fused bicyclic kinase inhibitors | OSI PHARMACEUTICALS LLC | 2013-03-13 | — | — | CN | disclosed |
| EP-1966164-B1 | NOVEL SUBSTITUTED PYRAZINONE DERIVATIVES FOR USE IN MCH-1 MEDIATED DISEASES | JANSSEN PHARMACEUTICA NV (BE) | 2013-03-06 | — | — | EP | disclosed |
| EP-2564446-A1 | ELECTROLUMINESCENT DEVICES BASED ON PHOSPHORESCENT IRIDIUM AND RELATED GROUP VIII METAL MULTICYCLIC COMPOUNDS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2013-03-06 | — | — | EP | disclosed |
| WO-2013026162-A1 | HEPATITIS C INHIBITOR COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-02-28 | — | — | WO | disclosed |
| US-20130023463-A1 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 2013-01-24 | — | — | US | disclosed |
| EP-2536285-A1 | SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | High Point Pharmaceuticals, LLC (US) | 2012-12-26 | — | — | EP | disclosed |
| US-8329704-B2 | Substituted pyrazinone derivatives for use in MCH-1 mediated diseases | JANSSEN PHARMACEUTICA, N.V. (BE) | 2012-12-11 | — | — | US | disclosed |
| WO-2012159959-A1 | 2-AMINO-3-(IMIDAZOL-2-YL)-PYRIDIN-4-ONE DERIVATIVES AND THEIR USE AS VEGF RECEPTOR KINASE INHIBITORS | SANOFI (FR) | 2012-11-29 | — | — | WO | disclosed |
| EP-2524915-A1 | 2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors | SANOFI (FR) | 2012-11-21 | — | — | EP | disclosed |
| US-8309721-B2 | HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof | SANOFI (FR) | 2012-11-13 | — | — | US | disclosed |
| EP-2216334-B1 | HIV protease inhibiting sulfonamides | ABBOTT LAB (US) | 2012-10-31 | — | — | EP | disclosed |
| US-8217031-B2 | Heteroaryl derivatives | NIPPON SHINYAKU CO., LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| US-8193227-B2 | HIV protease inhibiting compounds | ABBOTT LABORATORIES (US) | 2012-06-05 | — | — | US | disclosed |
| US-8178687-B2 | Derivatives of pyrroloindole which are inhibitors of Hsp90, compositions containing same, and use thereof | SANOFI-AVENTIS (FR) | 2012-05-15 | — | — | US | disclosed |
| EP-2419430-A2 | NOVEL COMPOUNDS OF REVERSE-TURN MIMETICS, METHOD FOR MANUFACTURING THE SAME AND USE THEREOF | JW Pharmaceutical Corporation (KR) | 2012-02-22 | — | — | EP | disclosed |
| EP-1697348-B1 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LAB (US) | 2011-12-28 | — | — | EP | disclosed |
| WO-2011151423-A1 | SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS | EXONHIT S.A. (FR) | 2011-12-08 | — | — | WO | disclosed |
| US-8063078-B2 | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain | GLAXOSMITHKLINE LLC (US) | 2011-11-22 | — | — | US | disclosed |
| WO-2011134013-A1 | ELECTROLUMINESCENT DEVICES BASED ON PHOSPHORESCENT IRIDIUM AND RELATED GROUP VIII METAL MULTICYCLIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2011-11-03 | — | — | WO | disclosed |
| EP-1697344-B1 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LAB (US) | 2011-09-28 | — | — | EP | disclosed |
| WO-2011103018-A1 | SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | HIGH POINT PHARMACEUTICALS, LLC (US) | 2011-08-25 | — | — | WO | disclosed |
| US-20110201604-A1 | Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof | HIGH POINT PHARMACEUTICALS, LLC (US) | 2011-08-18 | — | — | US | disclosed |
| US-20110184015-A1 | NOVEL DERIVATIVES OF PYRROLOINDOLE WHICH ARE INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME, AND USE THEREOF | SANOFI-AVENTIS (FR) | 2011-07-28 | — | — | US | disclosed |
| US-20110166169-A1 | NOVEL HSP90 INHIBITORY CARBAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME AND USE THEREOF | SANOFI-AVENTIS (FR) | 2011-07-07 | — | — | US | disclosed |
| EP-2298757-A2 | Urea compounds active as vanilloid receptor antagonist for the treatment of pain | Glaxo Group Limited (GB) | 2011-03-23 | — | — | EP | disclosed |
| EP-1641795-B1 | TRIAZA- AND TETRAAZA-ANTHRACENEDIONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2011-03-09 | — | — | EP | disclosed |
| US-20110053932-A1 | Protein Kinase Inhibitors and Methods for Using Thereof | IRM LLC | 2011-03-03 | — | — | US | disclosed |
| US-20110003827-A1 | HIV protease inhibiting compounds | ABBVIE INC. | 2011-01-06 | — | — | US | disclosed |
| EP-2266971-A2 | Hiv protease inhibiting compounds | Abbott Laboratories (US) | 2010-12-29 | — | — | EP | disclosed |
| EP-2264032-A2 | Hiv protease inhibiting sulfonamides | Abbott Laboratories (US) | 2010-12-22 | — | — | EP | disclosed |
| US-7834043-B2 | Prevent reproduct of aids virus | ABBOTT LABORATORIES (US) | 2010-11-16 | — | — | US | disclosed |
| US-20100267672-A1 | NOVEL COMPOUNDS OF REVERSE-TURN MIMETICS, METHOD FOR MANUFACTURING THE SAME AND USE THEREOF | CHOONGWAE PHARMA CORPORATION (KR) | 2010-10-21 | — | — | US | disclosed |
| WO-2010120112-A2 | NOVEL COMPOUNDS OF REVERSE-TURN MIMETICS, METHOD FOR MANUFACTURING THE SAME AND USE THEREOF | CHOONGWAE PHARMA CORPORATION (KR) | 2010-10-21 | — | — | WO | disclosed |
| US-20100249181-A1 | HIV Protease Inhibiting Compounds | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | US | disclosed |
| EP-1349005-B1 | Photosensitive compound, resin and composition | TOYO GOSEI CO LTD (JP) | 2010-09-01 | — | — | EP | disclosed |
| EP-2216334-A1 | Hiv protease inhibiting sulfonamides | Abbott Laboratories (US) | 2010-08-11 | — | — | EP | disclosed |
| US-7696226-B2 | HIV protease inhibiting compounds | ABBOTT LABORATORIES (US) | 2010-04-13 | — | — | US | disclosed |
| EP-2170842-A1 | PROTEIN KINASE INHIBITORS AND METHODS FOR USING THEREOF | IRM, LLC (BM) | 2010-04-07 | — | — | EP | disclosed |
| US-20100048537-A1 | HETEROARYL DERIVATIVES | NIPPON SHINYAKU CO., LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-7645799-B2 | Substituted biaryl compounds as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-01-12 | — | — | US | disclosed |
| EP-2141168-A1 | HETEROARYL DERIVATIVES | Nippon Shinyaku Co., Ltd. (JP) | 2010-01-06 | — | — | EP | disclosed |
| CN-101616909-A | Substituted isoquinoline 99.9 and isoquinolinone derivatives as the Rho-kinase inhibitor | SANOFI AVENTIS | 2009-12-30 | — | — | CN | disclosed |
| EP-1709037-B1 | HIV PROTEASE INHIBITING SULFONAMIDES | ABBOTT LAB (US) | 2009-12-23 | — | — | EP | disclosed |
| US-20090305983-A1 | Curable Bone Cement | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-12-10 | — | — | US | disclosed |
| CN-101573353-A | Substituted isoquinoline and isoquinolinone derivatives | SANOFI AVENTIS (FR) | 2009-11-04 | — | — | CN | disclosed |
| US-7592401-B2 | Multinuclear half metallocene catalyst and method for preparing syndiotatic polystyrene using the same | LG CHEM, LTD. (KR) | 2009-09-22 | — | — | US | disclosed |
| US-20090169532-A1 | CURABLE BONE CEMENT | AGENCY OF SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-07-02 | — | — | US | disclosed |
| US-20090163506-A1 | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain | SMITHKLINE BEECHAM PLC. (GB) | 2009-06-25 | — | — | US | disclosed |
| US-20090137597-A1 | Novel quinoxalinone derivatives | MSD K.K. (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-1425277-B8 | UREA-COMPOUNDS ACTIVE AS VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN | GLAXO GROUP LTD (GB) | 2009-04-01 | — | — | EP | disclosed |
| EP-2036902-A2 | Urea compounds active as vanilloid receptor antagonist for the treatment of pain | Glaxo Group Limited (GB) | 2009-03-18 | — | — | EP | disclosed |
| US-20090062287-A1 | SUBSTITUTED BIARYL COMPOUNDS AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2009-03-05 | — | — | US | disclosed |
| US-20090012062-A1 | Novel Substituted Pyrazinone Derivatives for Use in Mch-1 Mediated Diseases | BIOFOCUS DISCOVERY LTD. (GB) | 2009-01-08 | — | — | US | disclosed |
| WO-2008157575-A1 | PROTEIN KINASE INHIBITORS AND METHODS FOR USING THEREOF | IRM LLC (BM) | 2008-12-24 | — | — | WO | disclosed |
| CN-100441188-C | Benzazepine * derivatives as MAO-B inhibitors | HOFFMANN LA ROCHE (CH) | 2008-12-10 | — | — | CN | disclosed |
| US-7459564-B2 | Substituted biaryl compounds as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-12-02 | — | — | US | disclosed |
| EP-1363993-A4 | METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK) | BRISTOL MYERS SQUIBB CO (US) | 2008-11-12 | — | — | EP | disclosed |
| EP-1988938-A1 | CURABLE BONE CEMENT | Agency for Science, Technology and Research (SG) | 2008-11-12 | — | — | EP | disclosed |
| EP-1680127-B1 | BENZAZEPINE DERIVATIVES AS MAO-B INHIBITORS | HOFFMANN LA ROCHE (CH) | 2008-10-15 | — | — | EP | disclosed |
| EP-1966164-A1 | NOVEL SUBSTITUTED PYRAZINONE DERIVATIVES FOR USE IN MCH-1 MEDIATED DISEASES | Janssen Pharmaceutica, N.V. (BE) | 2008-09-10 | — | — | EP | disclosed |
| US-7420035-B2 | Purification of polypeptides | Atheris Laboratories, Dr. Reto Stocklin et Sylvie Stocklin Associes (CH) | 2008-09-02 | — | — | US | disclosed |
| US-20080194872-A1 | PURIFICATION OF POLYPEPTIDES | UNIVERSITE DE GENEVE (CH) | 2008-08-14 | — | — | US | disclosed |
| CN-101228132-A | Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors | SANOFI AVENTIS (FR) | 2008-07-23 | — | — | CN | disclosed |
| CN-101228149-A | Piperidinyl-substituted isoquinolinone derivatives as Rho-kinase inhibitors | SANOFI AVENTIS (FR) | 2008-07-23 | — | — | CN | disclosed |
| US-7388010-B2 | Quinoxalinone derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-06-17 | — | — | US | disclosed |
| US-20080070867-A1 | 2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases | METABASIS THERAPEUTICS, INC. (US) | 2008-03-20 | — | — | US | disclosed |
| EP-1828123-A1 | INDOLINONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS | Boehringer Ingelheim International GmbH (DE) | 2007-09-05 | — | — | EP | disclosed |
| WO-2007097710-A1 | CURABLE BONE CEMENT | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2007-08-30 | — | — | WO | disclosed |
| WO-2007071646-A1 | NOVEL SUBSTITUTED PYRAZINONE DERIVATIVES FOR USE IN MCH-1 MEDIATED DISEASES | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-06-28 | — | — | WO | disclosed |
| US-20070117791-A1 | Bicyclic compounds | JOLIDON SYNESE | 2007-05-24 | — | — | US | disclosed |
| US-20070100095-A1 | Multinuclear half metallocene catalyst and method for preparing syndiotatic polystyren using the same | LG CHEM, LTD. (KR) | 2007-05-03 | — | — | US | disclosed |
| EP-1777230-A1 | Multinuclear half metallocene catalyst and method for preparing syndiotactic polystyrene using the same | LG Chem Ltd. (KR) | 2007-04-25 | — | — | EP | disclosed |
| US-20070088051-A1 | INDOLINONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-04-19 | — | — | US | disclosed |
| US-20070072096-A1 | Negative curable dye-containing composition, color filter, and method of manufacturing the same | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| US-7173023-B2 | Bicyclic compounds | HOFFMANN-LA ROCHE INC. (US) | 2007-02-06 | — | — | US | disclosed |
| CN-1871013-A | Benzazepine derivatives as MAO-B inhibitors | HOFFMANN LA ROCHE (CH) | 2006-11-29 | — | — | CN | disclosed |
| US-7132536-B2 | Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-11-07 | — | — | US | disclosed |
| EP-1709037-A2 | HIV PROTEASE INHIBITING SULFONAMIDES | ABBOTT LABORATORIES (US) | 2006-10-11 | — | — | EP | disclosed |
| EP-1697348-A1 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 2006-09-06 | — | — | EP | disclosed |
| EP-1697344-A2 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 2006-09-06 | — | — | EP | disclosed |
| WO-2006078698-A1 | 2-IMIDAZOLONE AND 2-IMIDAZOLIDINONE HETEROCYCLIC INHIBITORS OF TYROSINE PHOSPHATASES | CENGENT THERAPEUTICS, INC. (US) | 2006-07-27 | — | — | WO | disclosed |
| EP-1680127-A1 | BENZAZEPINE DERIVATIVES AS MAO-B INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2006-07-19 | — | — | EP | disclosed |
| US-20060154915-A1 | Substituted biaryl compounds as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2006-07-13 | — | — | US | disclosed |
| WO-2006064044-A1 | INDOLINONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-06-22 | — | — | WO | disclosed |
| US-20060135592-A1 | Indolinones and their use as antiproliferative agents | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-06-22 | — | — | US | disclosed |
| EP-1641795-A1 | TRIAZA- AND TETRAAZA-ANTHRACENEDIONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-04-05 | — | — | EP | disclosed |
| EP-1325009-B1 | AMINO-SUBSTITUTED TETRACYCLIC COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | BRISTOL MYERS SQUIBB CO (US) | 2006-03-08 | — | — | EP | disclosed |
| US-20060019959-A1 | Novel quinoxalinone derivatives | BANYU PHARMACEUTICAL CO., LTD. TSUKUBA RESEARCH INSTITUTE (JP) | 2006-01-26 | — | — | US | disclosed |
| US-6960585-B2 | Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-11-01 | — | — | US | disclosed |
| EP-1557418-A1 | NOVEL QUINOXALINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2005-07-27 | — | — | EP | disclosed |
| US-20050159469-A1 | HIV protease inhibiting compounds | ABBVIE INC. | 2005-07-21 | — | — | US | disclosed |
| WO-2005061450-A2 | HIV PROTEASE INHIBITING SULFONAMIDES | ABBOTT LABORATORIES (US) | 2005-07-07 | — | — | WO | disclosed |
| WO-2005061487-A1 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 2005-07-07 | — | — | WO | disclosed |
| US-20050148623-A1 | Prevent reproduct of aids virus | ABBVIE INC. | 2005-07-07 | — | — | US | disclosed |
| WO-2005058841-A2 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 2005-06-30 | — | — | WO | disclosed |
| US-20050131042-A1 | HIV protease inhibiting compounds | ABBOTT LABORATORIES | 2005-06-16 | — | — | US | disclosed |
| US-20050131017-A1 | HIV protease inhibiting compounds | ABBOTT LABORATORIES | 2005-06-16 | — | — | US | disclosed |
| US-20050107360-A1 | Bicyclic compounds | HOFFMANN-LA ROCHE INC. | 2005-05-19 | — | — | US | disclosed |
| WO-2005039591-A1 | BENZAZEPINE DERIVATIVES AS MAO-B INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2005-05-06 | — | — | WO | disclosed |
| US-6869956-B2 | Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK) | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-03-22 | — | — | US | disclosed |
| US-6861456-B2 | Photosensitive compound, photosensitive resin, and photosensitive composition | TOYO GOSEI KOGYO CO., LTD. (JP) | 2005-03-01 | — | — | US | disclosed |
| US-20050025740-A1 | Polyoxime compounds and their preparation | AMYLIN PHARMACEUTICALS, INC. | 2005-02-03 | — | — | US | disclosed |
| US-20040266901-A1 | NOVEL PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE RESIN, AND PHOTOSENSITIVE COMPOSITION | TOYO GOSEI KOGYO CO., LTD. (JP) | 2004-12-30 | — | — | US | disclosed |
| US-20040248900-A1 | Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-12-09 | — | — | US | disclosed |
| WO-2004094425-A1 | Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2004-11-04 | — | — | WO | disclosed |
| EP-1471066-A1 | Triaza- and tetraaza-anthracenedione derivates, their preparation and their use as pharmaceuticals | Aventis Pharma Deutschland GmbH (DE) | 2004-10-27 | — | — | EP | disclosed |
| EP-1425277-A2 | UREA-COMPOUNDS ACTIVE AS VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN | SmithKline Beecham P.L.C. (GB) | 2004-06-09 | — | — | EP | disclosed |
| JP-2004143056-A | METHOD FOR PRODUCING 2-MERCAPTOIMIDAZOLES | NIPPON SYNTHETIC CHEM IND CO LTD:THE | 2004-05-20 | — | — | JP | disclosed |
| US-6709679-B2 | CONSISTING OF NATIVE OR THIOLATED TRANSFERRIN OR ALBUMIN OR OF POLYETHYLENE GLYCOL WITH ATLEAST ONE MERCAPTAN, HYDROXY OR AMINE GROUP AND CYTOSTATIC COMPOUNDS DERIVED THROUGH MALEINIMIDE OR HYDROXYSUCCINIMIDE ESTER COMPOUNDS | KRATZ FELIX (DE) | 2004-03-23 | — | — | US | disclosed |
| US-6663869-B1 | Linkages between polypeptide organic molecules are oxime linkages formed by reaction of a keto, aldehyde or amino-oxy group on the amino acid | GRYPHON THERAPEUTICS, INC. | 2003-12-16 | — | — | US | disclosed |
| EP-1363993-A2 | METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK) | Bristol-Myers Squibb Company (US) | 2003-11-26 | — | — | EP | disclosed |
| EP-1349005-A1 | Photosensitive compound, resin and composition | Toyo Gosei Kogyo Co., Ltd. (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20030135031-A1 | Purification of polypeptides | ATHERIS LABORATORIES, DR RETO STOCKLIN (CH) | 2003-07-17 | — | — | US | disclosed |
| EP-1325009-A2 | AMINO-SUBSTITUTED TETRACYCLIC COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | Bristol-Myers Squibb Company (US) | 2003-07-09 | — | — | EP | disclosed |
| EP-1137798-A4 | A METHOD OF ISOLATING STEM CELLS | UNIV DUKE (US) | 2003-06-25 | — | — | EP | disclosed |
| WO-2003022809-A2 | UREA-COMPOUNDS ACTIVE AS VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-03-20 | — | — | WO | disclosed |
| US-20030022898-A1 | Methods of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK) | BRISTOL-MYERS SQUIBB COMPANY | 2003-01-30 | — | — | US | disclosed |
| EP-1274722-A2 | PURIFICATION OF POLYPEPTIDES | UNIVERSITE DE GENEVE (CH) | 2003-01-15 | — | — | EP | disclosed |
| US-6479436-B1 | SUCH AS 2-(8-BROMOQUINOLIN-5-YL)CARBONYL-1,3-CYCLOHEXANEDIONE | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-12 | — | — | US | disclosed |
| WO-2002020493-A3 | A TRACELESS SOLID-PHASE SYNTHESIS OF 2-IMIDAZOLONES | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2002-10-31 | — | — | WO | disclosed |
| WO-2002060386-A2 | METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK) | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-08-08 | — | — | WO | disclosed |
| US-20020072523-A1 | Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same | BRISTOL-MYERS SQUIBB COMPANY | 2002-06-13 | — | — | US | disclosed |
| WO-2002028860-A2 | AMINO-SUBSTITUTED TETRACYCLIC COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-04-11 | — | — | WO | disclosed |
| WO-2002020493-A2 | A TRACELESS SOLID-PHASE SYNTHESIS OF 2-IMIDAZOLONES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002020493-A2 | A TRACELESS SOLID-PHASE SYNTHESIS OF 2-IMIDAZOLONES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-03-14 | — | — | WO | disclosed |
| US-20020019343-A1 | Antineoplastic conjugates of transferrin, albumin and polyethylene glycol | KRATZ FELIX (DE) | 2002-02-14 | — | — | US | disclosed |
| WO-2001081367-A2 | PURIFICATION OF POLYPEPTIDES | UNIVERSITE DE GENEVE (CH) | 2001-11-01 | — | — | WO | disclosed |
| US-6310039-B1 | TUMOR-INHIBITING CONJUGATES OF PROTEINS AND POLYMERS CONSISTING OF A SUITABLE CARRIER SYSTEM AND CYTOSTATIC COMPOUNDS | KRATZ FELIX (DE) | 2001-10-30 | — | — | US | disclosed |
| EP-1137798-A1 | A METHOD OF ISOLATING STEM CELLS | DUKE UNIVERSITY (US) | 2001-10-04 | — | — | EP | disclosed |
| EP-0741709-B1 | AROMATIC 2-AMINO-IMIDAZOLE DERIVATIVES AS ALPHA-2A ADRENOCEPTOR AGONISTS | ALLERGAN SALES INC (US) | 2001-07-25 | — | — | EP | disclosed |
| US-6262074-B1 | 4-Hetaroylpyrazol derivatives and the use thereof as herbicides | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-17 | — | — | US | disclosed |
| US-6217873-B1 | HOMOGENEOUS; MEDICAL DIAGNOSIS | GRYPHON SCIENCES | 2001-04-17 | — | — | US | disclosed |
| US-6174530-B1 | Homogeneous polyoxime compositions and their preparation by parallel assembly | GRYPHON SCIENCES | 2001-01-16 | — | — | US | disclosed |
| US-6114390-A | AN ARGININAMIDE OR ORNITHINAMIDE COMPOUND AS TREATING MEMORY LOSS, MIGRAINE, SLEEP DISORDERS, PAIN, CARDIOVASCULAR DISEASES, SUBARACHNOIDAL BLEEDING, VASCULAR-HYPERTROPHIC CHANGES, CEREBRAL AND CORONARY VASOSPASMS | KARL THOMAE GMBH (DE) | 2000-09-05 | — | — | US | disclosed |
| WO-2000034507-A1 | A METHOD OF ISOLATING STEM CELLS | DUKE UNIVERSITY (US) | 2000-06-15 | — | — | WO | disclosed |
| EP-0697891-B1 | POLYOXIME COMPOUNDS AND THEIR PREPARATION | ROSE KEITH (CH) | 2000-03-29 | — | — | EP | disclosed |
| US-6001364-A | COMPRISING A BASEPLATE STRUCTURE HAVING A PLURALITY OF OXIME BONDS, WHEREIN EACH OXIME BOND LINKS A SPECIFICALLY ACTIVE MOLECULE TO THE BASEPLATE; FOR INDUCING AN IMMUNE RESPONSE IN AN ANIMAL | GRYPHON SCIENCES (US) | 1999-12-14 | — | — | US | disclosed |
| CN-1235600-A | 4-hetaroylpyrazol derivatives | BASF AG (DE) | 1999-11-17 | — | — | CN | disclosed |
| CN-1230951-A | Herbicidal heteroaroyl cyclohexanedione derivatives | BASF AG (DE) | 1999-10-06 | — | — | CN | disclosed |
| WO-1999007750-A1 | PERFLUORINATED RESINS AS A SUPPORT FOR SOLID PHASE REACTIONS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) | 1999-02-18 | — | — | WO | disclosed |
| EP-0885186-A1 | AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM | Dr. Karl Thomae GmbH (DE) | 1998-12-23 | — | — | EP | disclosed |
| WO-1998046593-A1 | NOVEL CARBOSTYRIL DERIVATIVE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-22 | — | — | WO | disclosed |
| EP-0500045-B1 | Process of processing silver halide photographic material and photographic processing composition having a fixing ability | FUJI PHOTO FILM CO LTD (JP) | 1998-05-13 | — | — | EP | disclosed |
| WO-1997019911-A1 | AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM | DR. KARL THOMAE GMBH (DE) | 1997-06-05 | — | — | WO | disclosed |
| EP-0741709-A1 | AROMATIC 2-AMINO-IMIDAZOLE DERIVATIVES AS ALPHA-2A ADRENOCEPTOR AGONISTS | Allergan (US) | 1996-11-13 | — | — | EP | disclosed |
| US-5532233-A | PLATELET ACTIVATING FACTOR ANTAGONIST | BOEHRINGER INGELHEIM KG (DE) | 1996-07-02 | — | — | US | disclosed |
| US-5521177-A | ANGIOTENSIN ANTAGONIST FOR CARDIOVASCULAR DISORDERS SUCH AS ISCHEMIA OR CENTRAL NERVOUS SYSTEM DISORDERS SUCH AS COGNITIVE FUNCTIONS, DEPRESSION, ALZHEIMER'S DISEASE OR PARKINSON'S SYNDROME | DR. KARL THOMAE GMBH (DE) | 1996-05-28 | — | — | US | disclosed |
| US-5514694-A | ENZYME INHIBITORS | GEORGIA TECH RESEARCH CORP (US) | 1996-05-07 | — | — | US | disclosed |
| EP-0697891-A1 | POLYOXIME COMPOUNDS AND THEIR PREPARATION | Rose, Keith (CH) | 1996-02-28 | — | — | EP | disclosed |
| WO-1995019968-A1 | AROMATIC 2-AMINO-IMIDAZOLE DERIVATIVES AS ALPHA-2A ADRENOCEPTOR AGONISTS | ALLERGAN (US) | 1995-07-27 | — | — | WO | disclosed |
| EP-0650368-A1 | USE OF CALPAIN INHIBITORS IN THE INHIBITION AND TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH INCREASED CALPAIN ACTIVITY | CORTEX PHARMACEUTICALS, INC. (US) | 1995-05-03 | — | — | EP | disclosed |
| EP-0249239-B1 | Process for the formation of direct positive images | FUJI PHOTO FILM CO LTD (JP) | 1995-01-25 | — | — | EP | disclosed |
| EP-0249938-B1 | Imidazolesulfonamide derivatives, herbicides and a method for inhibiting growth of undesirable plants | NISSAN CHEMICAL IND LTD (JP) | 1994-12-14 | — | — | EP | disclosed |
| WO-1994025071-A1 | POLYOXIME COMPOUNDS AND THEIR PREPARATION | ROSE KEITH (CH) | 1994-11-10 | — | — | WO | disclosed |
| EP-0244803-B1 | Novel dopamine beta hydroxylase inhibitors | MERRELL DOW PHARMA (US) | 1994-10-26 | — | — | EP | disclosed |
| US-5338648-A | Process of processing silver halide photographic material and photographic processing composition having a fixing ability | FUJI PHOTO FILM CO., LTD. (JP) | 1994-08-16 | — | — | US | disclosed |
| CN-1088202-A | Benzoglyoxaline contains pharmaceutical composition of these compounds and preparation method thereof | THOMAE GMBH DR K (DE) | 1994-06-22 | — | — | CN | disclosed |
| EP-0389189-B1 | Diazepine antiallergy agents | PFIZER LTD (GB) | 1994-05-18 | — | — | EP | disclosed |
| WO-1994000095-A2 | USE OF CALPAIN INHIBITORS IN THE INHIBITION AND TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH INCREASED CALPAIN ACTIVITY | CORTEX PHARMACEUTICALS, INC. (US) | 1994-01-06 | — | — | WO | disclosed |
| US-5162534-A | Process for the preparation of thiazoline derivatives | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1992-11-10 | — | — | US | disclosed |
| EP-0283041-B1 | DIRECT POSITIVE SILVER HALIDE PHOTOSENSITIVE MATERIAL AND METHOD FOR FORMING DIRECT POSITIVE IMAGE | FUJI PHOTO FILM CO., LTD. (JP) | 1992-10-07 | — | — | EP | disclosed |
| EP-0500045-A1 | Process of processing silver halide photographic material and photographic processing composition having a fixing ability | FUJI PHOTO FILM CO., LTD. (JP) | 1992-08-26 | — | — | EP | disclosed |
| EP-0260814-B1 | DOPAMINE-BETA-HYDROXYLASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1992-02-05 | — | — | EP | disclosed |
| EP-0238060-B1 | CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS | Banyu Pharmaceutical Co., Ltd. (JP) | 1992-01-08 | — | — | EP | disclosed |
| EP-0166937-B1 | ADRENERGIC COMPOUNDS | ABBOTT LABORATORIES (US) | 1991-08-28 | — | — | EP | disclosed |
| US-5008263-A | Platelet activating factor antagonists; antiallergens; antiinflammatory agents | PFIZER INC. (US) | 1991-04-16 | — | — | US | disclosed |
| US-4992459-A | Hypotensive agents, antiulcer agents | SMITHKLINE BEECHAM CORPORATION (US) | 1991-02-12 | — | — | US | disclosed |
| EP-0404694-A2 | 4-hydroxy-8-methoxy-2-methyl-6, 7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline, and process for preparing the same | MITSUBISHI KASEI CORPORATION (JP) | 1990-12-27 | — | — | EP | disclosed |
| EP-0212066-B1 | INTERMEDIATES USEFUL IN THE PREPARATION OF DOPAMINE-BETA-HYDROXYLASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1990-11-22 | — | — | EP | disclosed |
| US-4963684-A | OXIDATION AMINO GROUP OF A TETRAHYDROISOQUINOLINE COMPOUND; HYDROLYSIS | MITSUBISHI KASEI CORPORATION (JP) | 1990-10-16 | — | — | US | disclosed |
| CN-1045783-A | Diaza class anti-allergy medicament | PFIZER (US) | 1990-10-03 | — | — | CN | disclosed |
| EP-0389189-A2 | Diazepine antiallergy agents | Pfizer Limited (GB) | 1990-09-26 | — | — | EP | disclosed |
| EP-0387156-A2 | A process for preparing cotarnine | MITSUBISHI KASEI CORPORATION (JP) | 1990-09-12 | — | — | EP | disclosed |
| EP-0288488-A4 | DOPAMINE- -HYDROXYLASE INHIBITORS | — | 1990-09-12 | — | — | EP | disclosed |
| US-4954427-A | Development of light-sensitive material in the presence of a nucleating agent and a nuceation accelerator | FUJI PHOTO FILM CO., LTD. (JP) | 1990-09-04 | — | — | US | disclosed |
| US-4952483-A | NOVEL HYDRAZINE NUCLEATING AGENTS AND ACCELERATORS | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-28 | — | — | US | disclosed |
| US-4933265-A | NUCLEATION PROMOTER | FUJI PHOTO FILM CO., LTD. (JP) | 1990-06-12 | — | — | US | disclosed |
| EP-0140640-B1 | BLOOD SUBSTITUTE | FISONS plc (GB) | 1990-04-04 | — | — | EP | disclosed |
| US-4873357-A | Trifluoro acetyl-cyano-aniline intermediates for dopamine-βhydroxylase inhibitors | SMITHKLINE BECKMAN CORPORATION (US) | 1989-10-10 | — | — | US | disclosed |
| US-4863944-A | Dopamine-β-hydroxylase inhibitors | SMITHKLINE BECKMAN CORPORATION (US) | 1989-09-05 | — | — | US | disclosed |
| US-4839365-A | Thienopyridine derivatives useful in treating gastric ulcers | SHINOGI & CO., LTD. (JP) | 1989-06-13 | — | — | US | disclosed |
| US-4830660-A | Imidazolesulfonamide derivatives and herbicides | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1989-05-16 | — | — | US | disclosed |
| EP-0125033-B1 | DOPAMINE-BETA-HYDROXYLASE INHIBITORS | SMITHKLINE BECKMAN CORPORATION (US) | 1989-04-26 | — | — | EP | disclosed |
| EP-0308573-A2 | Intermediates useful in the preparation of dopamine-beta-hydroxylase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1989-03-29 | — | — | EP | disclosed |
| US-4814328-A | Cephalosporin derivatives, and antibacterial agents | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-03-21 | — | — | US | disclosed |
| US-4810800-A | HYPOTENSIVE AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-03-07 | — | — | US | disclosed |
| EP-0125783-B1 | DOPAMINE-BETA-HYDROXYLASE INHIBITORS | SMITHKLINE BECKMAN CORPORATION (US) | 1989-01-04 | — | — | EP | disclosed |
| EP-0292051-A2 | Thienopyridine derivatives | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1988-11-23 | — | — | EP | disclosed |
| US-4785010-A | AGING RESISTANCE OF HUMANS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1988-11-15 | — | — | US | disclosed |
| EP-0288488-A1 | DOPAMINE- -HYDROXYLASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1988-11-02 | — | — | EP | disclosed |
| US-4782155-A | ISOQUINOLINE SALTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1988-11-01 | — | — | US | disclosed |
| EP-0283041-A1 | Direct positive silver halide photosensitive material and method for forming direct positive image | FUJI PHOTO FILM CO., LTD. (JP) | 1988-09-21 | — | — | EP | disclosed |
| US-4772723-A | Dopamine β-hydroxylase inhibitors | SMITHKLINE BECKMAN CORPORATION (US) | 1988-09-20 | — | — | US | disclosed |
| US-4769480-A | Benzylamine derivative | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1988-09-06 | — | — | US | disclosed |
| US-4761480-A | DOPAMINE-BETA-HYDROXYLASE INHIBITORS | SMITHKLINE BECKMAN CORPORATION (US) | 1988-08-02 | — | — | US | disclosed |
| US-4760145-A | Certain 6,7-methylene dioxydihydro or tetrahydro-isoquinoline derivatives | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1988-07-26 | — | — | US | disclosed |
| US-4743613-A | Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity | SMITHKLINE BECKMAN CORPORATION (US) | 1988-05-10 | — | — | US | disclosed |
| EP-0260814-A1 | Dopamine-Beta-hydroxylase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1988-03-23 | — | — | EP | disclosed |
| WO-1988001267-A1 | DOPAMINE-ss-HYDROXYLASE INHIBITORS | SMITHKLINE BECKMAN CORPORATION (US) | 1988-02-25 | — | — | WO | disclosed |
| US-4719223-A | ENZYME INHIBITORS, HYPOTENSIVE, CARDIOTONIC DIURETIC | SMITHKLINE BECKMAN CORPORATION (US) | 1988-01-12 | — | — | US | disclosed |
| EP-0249938-A2 | Imidazolesulfonamide derivatives, herbicides and a method for inhibiting growth of undesirable plants | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1987-12-23 | — | — | EP | disclosed |
| EP-0249239-A2 | Process for the formation of direct positive images | FUJI PHOTO FILM CO., LTD. (JP) | 1987-12-16 | — | — | EP | disclosed |
| US-4710488-A | SYNTHETIC BLOOD; LOW OXYGEN AFFINITY | FISONS PLC (GB) | 1987-12-01 | — | — | US | disclosed |
| EP-0244803-A2 | Novel dopamine beta hydroxylase inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1987-11-11 | — | — | EP | disclosed |
| EP-0244956-A1 | Ester prodrugs of dopamine-beta-hydroxylase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1987-11-11 | — | — | EP | disclosed |
| US-4701556-A | 7-(IMIDAZOL-2-YL-AMINO) CEPHEMS AND OXACEPHEMS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-10-20 | — | — | US | disclosed |
| EP-0238060-A2 | Cephalosporin derivatives, processes for their preparation and antibacterial agents | Banyu Pharmaceutical Co., Ltd. (JP) | 1987-09-23 | — | — | EP | disclosed |
| EP-0221778-A2 | Dopamine-beta-hydroxylase inhibitors | SMITHKLINE BECKMAN CORPORATION (US) | 1987-05-13 | — | — | EP | disclosed |
| EP-0216696-A2 | Process for preparing cotarnine | MITSUBISHI KASEI CORPORATION (JP) | 1987-04-01 | — | — | EP | disclosed |
| EP-0214740-A2 | Dopamine-beta-hydroxylase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1987-03-18 | — | — | EP | disclosed |
| EP-0214905-A2 | Tetrahydroisoquinoline derivatives | MITSUBISHI KASEI CORPORATION (JP) | 1987-03-18 | — | — | EP | disclosed |
| US-4650786-A | OXYGENATION OF TISSUES | FISONS PLC (GB) | 1987-03-17 | — | — | US | disclosed |
| EP-0214051-A2 | Benzylamine derivative | MITSUBISHI KASEI CORPORATION (JP) | 1987-03-11 | — | — | EP | disclosed |
| EP-0212066-A1 | Intermediates useful in the preparation of dopamine-beta-hydroxylase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1987-03-04 | — | — | EP | disclosed |
| US-4634705-A | Adrenergic amidines | ABBOTT LABORATORIES (US) | 1987-01-06 | — | — | US | disclosed |
| US-4634711-A | ENZYME INHIBITORS | SMITHKLINE BECKMAN CORPORATION (US) | 1987-01-06 | — | — | US | disclosed |
| US-4610954-A | ANTIFOGGING AGENTS | FUJI PHOTO FILM CO., LTD. (JP) | 1986-09-09 | — | — | US | disclosed |
| US-4584384-A | HISTAMINE H2-ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1986-04-22 | — | — | US | disclosed |
| EP-0115400-B1 | TRIAZOLE ANTIFUNGAL AGENTS | Pfizer Limited (GB) | 1986-03-26 | — | — | EP | disclosed |
| EP-0166937-A2 | Adrenergic compounds | ABBOTT LABORATORIES (US) | 1986-01-08 | — | — | EP | disclosed |
| US-4554242-A | Method for processing color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1985-11-19 | — | — | US | disclosed |
| US-4540705-A | Antidepressant imidazolines and related compounds | STERLING DRUG INC. (US) | 1985-09-10 | — | — | US | disclosed |
| US-4532331-A | 1-Benzyl-2-aminomethyl imidazole derivatives | SMITHKLINE BECKMAN CORPORATION (US) | 1985-07-30 | — | — | US | disclosed |
| EP-0140640-A2 | Blood substitute | FISONS plc (GB) | 1985-05-08 | — | — | EP | disclosed |
| US-4497949-A | PHOTOTHERMOGRAPHY;COLOR FILMS;STORAGE STABILITY;ANTIFOGGING AGENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-02-05 | — | — | US | disclosed |
| EP-0125783-A1 | Dopamine-beta-hydroxylase inhibitors | SMITHKLINE BECKMAN CORPORATION (US) | 1984-11-21 | — | — | EP | disclosed |
| US-4483863-A | Triazole antifungal agents | PFIZER INC. (US) | 1984-11-20 | — | — | US | disclosed |
| EP-0125033-A1 | Dopamine-beta-hydroxylase inhibitors | SMITHKLINE BECKMAN CORPORATION (US) | 1984-11-14 | — | — | EP | disclosed |
| US-4482563-A | HISTAMINE H2-ANTAGONIST | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1984-11-13 | — | — | US | disclosed |
| EP-0115400-A1 | Triazole antifungal agents | Pfizer Limited (GB) | 1984-08-08 | — | — | EP | disclosed |
| US-4407808-A | 2-Heterocyclic alkylamino-3-nitropyrroles | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1983-10-04 | — | — | US | disclosed |
| EP-0086043-A1 | 2-(Phenoxyalkyl) imidazoles as ectoparasiticides and anthelmintics | Pfizer Limited (GB) | 1983-08-17 | — | — | EP | disclosed |
| EP-0005985-B1 | 3-NITRO PYRROLE COMPOUNDS, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1983-04-27 | — | — | EP | disclosed |
| EP-0072608-A2 | Process for the preparation of cephalosporin derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-02-23 | — | — | EP | disclosed |
| US-4353826-A | ANTITUBERCULAR ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1982-10-12 | — | — | US | disclosed |
| US-4331668-A | ANTIHISTAMINE, ANTAGONIST | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1982-05-25 | — | — | US | disclosed |
| US-4324792-A | SKIN DISORDERS, HAY FEVER, ASTHMA | GLAXO GROUP LIMITED (GB) | 1982-04-13 | — | — | US | disclosed |
| US-4294973-A | Process for the preparation of diacylated 4-imidazolin-2-ones | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-13 | — | — | US | disclosed |
| US-4282146-A | Preparation of 1,2,4,5-tetrahydro-7-alkoxy-(and 7,8-dialkoxy)-3H,3-benzazepines and 3-substituted derivatives thereof from the corresponding phenethylamines | PENNWALT CORPORATION (US) | 1981-08-04 | — | — | US | disclosed |
| US-4261891-A | BACTERICIDES, ANTITUBERCULAR AGENTS | CIBA-GEIGY CORPORATION (US) | 1981-04-14 | — | — | US | disclosed |
| US-4238494-A | HISTAMINE H2-RECEPTOR ANTAGONIST | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1980-12-09 | — | — | US | disclosed |
| US-4238618-A | Process for the preparation of diacylated 4-imidazolin-2-ones | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-09 | — | — | US | disclosed |
| EP-0005985-A1 | 3-Nitro pyrrole compounds, processes for preparing them and pharmaceutical compositions containing them | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-12-12 | — | — | EP | disclosed |
| US-4137268-A | Method of preparing aminoacetaldehyde acetals by the hydrogenation of dialkoxyacetonitrile | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1979-01-30 | — | — | US | disclosed |
| US-4137268-A | Method of preparing aminoacetaldehyde acetals by the hydrogenation of dialkoxyacetonitrile | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1979-01-30 | — | — | US | disclosed |
| US-4137268-A | Method of preparing aminoacetaldehyde acetals by the hydrogenation of dialkoxyacetonitrile | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1979-01-30 | — | — | US | disclosed |
| US-4098783-A | Dye substituted cyclic 1,3-sulfur-nitrogen compounds as dye image-forming materials in photography | POLAROID CORPORATION (US) | 1978-07-04 | — | — | US | disclosed |
| US-4005077-A | DERIVATIVES OF RIFAMYCIN S OR SV | CIBA-GEIGY CORPORATION (US) | 1977-01-25 | — | — | US | disclosed |
| US-4002742-A | 1-N-alkyl-4,6-di-(aminoglycosyl)-1,3-diaminocyclitols, methods for their manufacture, methods for their use as antibacterial agents, and compositions useful therefor | SCHERING CORPORATION (US) | 1977-01-11 | — | — | US | disclosed |
| US-3985881-A | 1(3,4,5-Trimethoxybenzamido methyl) tetrahydro isoquinoline derivatives and a process for their production | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-10-12 | — | — | US | disclosed |
| US-3952006-A | Thiophene derivatives | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JA) | 1976-04-20 | — | — | US | disclosed |
| US-3952006-A | Thiophene derivatives | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JA) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070867-A1 | 2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases | PPM1B, PPM1D, PTPRS | LMNA 3553/4885THRB 653/4885ALDH1A1 3704/4885 |
| US-20150368264-A1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | CPS1, SDHA, DHPS | LMNA 2030/4885THRB 4294/4885ALDH1A1 883/4885 |
| US-12091407-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | GLS, HMOX2, REN | LMNA 2765/4885THRB 2082/4885ALDH1A1 1872/4885 |
| US-20150328205-A1 | 2-AMINO-3-(IMIDAZOL-2-YL)-PYRIDIN-4-ONE DERIVATIVES AND THEIR USE AS VEGF RECEPTOR KINASE INHIBITORS | KDR, FLT4, FLT1 | LMNA 2922/4885THRB 753/4885ALDH1A1 1831/4885 |
| US-20110003827-A1 | HIV protease inhibiting compounds | SERPINB1, HPN, DNPEP | LMNA 3100/4885THRB 4644/4885ALDH1A1 2920/4885 |
| US-20050025740-A1 | Polyoxime compounds and their preparation | PCBP1, PAM, OGFOD1 | LMNA 2208/4885THRB 1492/4885ALDH1A1 4280/4885 |
| US-20190345137-A1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS HUMAN CHITINASE INHIBITORS | CHIA, CHIT1, AADAC | LMNA 4612/4885THRB 1287/4885ALDH1A1 1830/4885 |
| US-20200223866-A1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | CPS1, SDHA, DHPS | LMNA 2030/4885THRB 4294/4885ALDH1A1 883/4885 |
| US-20140179667-A1 | ARYL AND HETEROARYL FUSED LACTAMS | CCNY, MLX, NFXL1 | LMNA 1563/4885THRB 1883/4885ALDH1A1 2245/4885 |
| US-20160347760-A1 | Bicyclic-Fused Heteroaryl or Aryl Compounds | UGT2B7, CYP3A43, CYP3A4 | LMNA 1045/4885THRB 946/4885ALDH1A1 594/4885 |
| US-20020072523-A1 | Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same | IL4, IL4I1, MSR1 | LMNA 4706/4885THRB 2173/4885ALDH1A1 1556/4885 |
| US-20050148623-A1 | Prevent reproduct of aids virus | SERPINB1, PRSS1, SERPINA3 | LMNA 3063/4885THRB 4614/4885ALDH1A1 1209/4885 |
| US-20220169641-A1 | Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof | GLS, HMOX2, REN | LMNA 2765/4885THRB 2082/4885ALDH1A1 1872/4885 |
| US-20110166169-A1 | NOVEL HSP90 INHIBITORY CARBAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME AND USE THEREOF | HSP90AB2P, HSP90AB1, HSP90AA1 | LMNA 4578/4885THRB 1186/4885ALDH1A1 1673/4885 |
| US-11130753-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | GLS, HMOX2, REN | LMNA 2765/4885THRB 2082/4885ALDH1A1 1872/4885 |
| US-20110201604-A1 | Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof | HMOX2, HMOX1, PTGS2 | LMNA 3326/4885THRB 2161/4885ALDH1A1 1757/4885 |
| US-10287284-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | HMOX2, HMOX1, PTGS2 | LMNA 3326/4885THRB 2161/4885ALDH1A1 1757/4885 |
| US-20090012062-A1 | Novel Substituted Pyrazinone Derivatives for Use in Mch-1 Mediated Diseases | MCHR1, MCHR2, MC1R | LMNA 3860/4885THRB 391/4885ALDH1A1 954/4885 |
| US-20230312548-A1 | SUBSTITUTE FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | GLS, HMOX2, REN | LMNA 3422/4885THRB 2091/4885ALDH1A1 1697/4885 |
| US-20070088051-A1 | INDOLINONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS | MKI67, CCNT1, CCNA1 | LMNA 1271/4885THRB 2107/4885ALDH1A1 410/4885 |
| US-20160264549-A1 | SUBSTITUTED 6, 7-DIALKOXY-3-ISOQUINOLINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE 10A) | PDE9A, PDE10A, PDE6A | LMNA 4194/4885THRB 1615/4885ALDH1A1 186/4885 |
| US-20170233368-A1 | ARYL AND HETEROARYL FUSED LACTAMS | CCNY, MLX, NFXL1 | LMNA 1563/4885THRB 1883/4885ALDH1A1 2245/4885 |
| US-11649230-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | GLS, HMOX2, REN | LMNA 2765/4885THRB 2082/4885ALDH1A1 1872/4885 |
| US-20200148673-A1 | Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof | GOT2, GLS2, PYGL | LMNA 2621/4885THRB 1484/4885ALDH1A1 491/4885 |
| US-20040248900-A1 | Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals | CYP19A1, TBXAS1, CYP11B1 | LMNA 820/4885THRB 534/4885ALDH1A1 453/4885 |
| US-20150175572-A1 | ARYL AND HETEROARYL FUSED LACTAMS | CCNY, MLX, NFXL1 | LMNA 1563/4885THRB 1883/4885ALDH1A1 2245/4885 |
| US-20130023463-A1 | HIV PROTEASE INHIBITING COMPOUNDS | SERPINB1, HPN, DNPEP | LMNA 3100/4885THRB 4644/4885ALDH1A1 2920/4885 |
| US-20180022757-A1 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | CPS1, SDHA, DHPS | LMNA 2030/4885THRB 4294/4885ALDH1A1 883/4885 |
| US-20020019343-A1 | Antineoplastic conjugates of transferrin, albumin and polyethylene glycol | TFRC, ALB, FOLR1 | LMNA 3807/4885THRB 1186/4885ALDH1A1 2933/4885 |
| US-20190194181-A1 | Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof | HMOX2, HMOX1, UACA | LMNA 2940/4885THRB 2073/4885ALDH1A1 1046/4885 |
| US-20150284405-A1 | Bicyclic-Fused Heteroaryl or Aryl Compounds | UGT2B7, CYP3A43, CYP3A4 | LMNA 1045/4885THRB 946/4885ALDH1A1 594/4885 |
| US-20110184015-A1 | NOVEL DERIVATIVES OF PYRROLOINDOLE WHICH ARE INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME, AND USE THEREOF | HSP90AB1, HSP90AB2P, HSP90AA1 | LMNA 3855/4885THRB 2638/4885ALDH1A1 2129/4885 |
| US-20050107360-A1 | Bicyclic compounds | MAOB, MAOA, XDH | LMNA 751/4885THRB 952/4885ALDH1A1 630/4885 |
| US-20200385370-A1 | APPARATUS FOR REMOVING BAD ODOR FROM TOILET | IRAK4, IRAK1, IRAK2 | LMNA 4124/4885THRB 2394/4885ALDH1A1 828/4885 |
| US-20150307487-A1 | SMALL MOLECULES TARGETING REPEAT r(CGG) SEQUENCES | HNRNPM, RBM39, FUS | LMNA 943/4885THRB 1680/4885ALDH1A1 4710/4885 |
| US-20190270751-A1 | Bicyclic-Fused Heteroaryl or Aryl Compounds | UGT2B7, CYP3A43, CYP3A4 | LMNA 1045/4885THRB 946/4885ALDH1A1 594/4885 |
| US-20230381170-A1 | METHOD FOR TREATING ALS/FTD THROUGH DEGRADATION OF RNA REPEAT EXPANSION | RBM39, HNRNPC, HNRNPH3 | LMNA 234/4885THRB 4381/4885ALDH1A1 4690/4885 |
| US-20090163506-A1 | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain | TRPV1, OPRL1, UTS2R | LMNA 2498/4885THRB 1971/4885ALDH1A1 2656/4885 |
| US-20090137597-A1 | Novel quinoxalinone derivatives | NDUFB1, NDUFB6, NDUFB7 | LMNA 976/4885THRB 3593/4885ALDH1A1 975/4885 |
| US-20100267672-A1 | NOVEL COMPOUNDS OF REVERSE-TURN MIMETICS, METHOD FOR MANUFACTURING THE SAME AND USE THEREOF | MCL1, THPO, FLT3 | LMNA 781/4885THRB 318/4885ALDH1A1 3827/4885 |
| US-20160235759-A1 | Kappa Opioid Receptor Compounds | OPRK1, OPRL1, OPRD1 | LMNA 3939/4885THRB 249/4885ALDH1A1 1402/4885 |
| US-20110053932-A1 | Protein Kinase Inhibitors and Methods for Using Thereof | BMX, FRK, FYN | LMNA 3091/4885THRB 940/4885ALDH1A1 3388/4885 |
| US-20060154915-A1 | Substituted biaryl compounds as factor XIa inhibitors | TFPI, F3, F12 | LMNA 426/4885THRB 1210/4885ALDH1A1 4002/4885 |
| US-20150158895-A1 | SUBSTITUTED 6, 7-DIALKOXY-3-ISOQUINOLINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE 10A) | PDE9A, PDE10A, PDE6A | LMNA 4194/4885THRB 1615/4885ALDH1A1 186/4885 |
| US-20150038507-A1 | Antiprotozoal Compounds | TREH, MPO, TBCA | LMNA 1440/4885THRB 3017/4885ALDH1A1 390/4885 |
| US-20200377511-A1 | Bicyclic-Fused Heteroaryl or Aryl Compounds | UGT2B7, CYP3A43, CYP3A4 | LMNA 1045/4885THRB 946/4885ALDH1A1 594/4885 |
| US-20150291592-A1 | HEPATITIS C INHIBITOR COMPOUNDS | HAVCR2, CD4, HAX1 | LMNA 1423/4885THRB 1263/4885ALDH1A1 773/4885 |
| US-20050159469-A1 | HIV protease inhibiting compounds | SERPINB1, HPN, DNPEP | LMNA 3100/4885THRB 4644/4885ALDH1A1 2920/4885 |
| US-10030011-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | HMOX2, HMOX1, PTGS2 | LMNA 3326/4885THRB 2161/4885ALDH1A1 1757/4885 |
| US-10793579-B2 | Bicyclic-fused heteroaryl or aryl compounds | UGT2B7, CYP3A43, CYP3A4 | LMNA 1045/4885THRB 946/4885ALDH1A1 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.